Part 1: Clinical Trials and COVID-19: Situation now, its challenges, and the future

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome.

TransPerfect Life Sciences hosted Part 1 of the Clinical Trials and COVID-19 webinar series with industry experts to exchange ideas and provide insights into the impact of COVID-19 on clinical trials.

Moderator: Michael Smyth, Division President and Corporate Vice President, TransPerfect